Literature DB >> 20003695

Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV.

R Dawson1, P Masuka, D J Edwards, E D Bateman, L-G Bekker, R Wood, S D Lawn.   

Abstract

SETTING: An antiretroviral treatment (ART) service in Gugulethu township, Cape Town, South Africa.
OBJECTIVE: To assess the inter-observer agreement when using the chest radiographic reading and reporting system (CRRS) to detect radiographic abnormalities in patients with advanced human immunodeficiency virus (HIV) associated immunodeficiency being actively screened for tuberculosis (TB). Second, to assess the associated performance characteristics of radiology as a routine screening test for detection of culture-confirmed pulmonary TB.
DESIGN: Radiographs from a study in which patients were actively screened for TB just before starting ART were independently reported by two CRRS-certified readers blinded to clinical status.
RESULTS: Good kappa statistic agreements between observers were found when reporting any radiological abnormality consistent with TB among all patients (n = 203, kappa = 0.63, 95%CI 0.52-0.73) and among those with culture-confirmed TB (n = 53, kappa = 0.61, 95%CI 0.40-0.83). However, in comparison with sputum culture, the sensitivity (0.68, 95%CI 0.54-0.79) and specificity (0.53, 95%CI 0.45-0.61) of radiology in this patient group were low.
CONCLUSION: This study provides evidence of the good inter-observer agreement using the CRRS standardised reporting methodology when used among patients with advanced HIV-associated immunodeficiency and a high prevalence of culture-proven pulmonary TB. The utility of radiology as a screening test for TB in this patient group, however, remains limited.

Entities:  

Mesh:

Year:  2010        PMID: 20003695      PMCID: PMC3647461     

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  29 in total

1.  Studies on the accuracy of diagnostic procedures.

Authors:  L H GARLAND
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1959-07

2.  Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control.

Authors:  Robin Wood; Keren Middelkoop; Landon Myer; Alison D Grant; Andrew Whitelaw; Stephen D Lawn; Gilla Kaplan; Robin Huebner; James McIntyre; Linda-Gail Bekker
Journal:  Am J Respir Crit Care Med       Date:  2006-09-14       Impact factor: 21.405

3.  Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa.

Authors:  Linda-Gail Bekker; Landon Myer; Catherine Orrell; Steve Lawn; Robin Wood
Journal:  S Afr Med J       Date:  2006-04

4.  Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.

Authors:  Stephen D Lawn; Landon Myer; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2007-01-30       Impact factor: 4.177

5.  Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.

Authors:  Stephen D Lawn; Landon Myer; Catherine Orrell; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2005-12-02       Impact factor: 4.177

6.  High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania.

Authors:  Lillian Mtei; Mecky Matee; Oliver Herfort; Muhammad Bakari; C Robert Horsburgh; Richard Waddell; Bernard F Cole; Jenni M Vuola; Susan Tvaroha; Barry Kreiswirth; Kisali Pallangyo; C Fordham von Reyn
Journal:  Clin Infect Dis       Date:  2005-04-12       Impact factor: 9.079

7.  Pulmonary tuberculosis: radiological features in west Africans coinfected with HIV.

Authors:  S D Lawn; A J Evans; P M Sedgwick; J W Acheampong
Journal:  Br J Radiol       Date:  1999-04       Impact factor: 3.039

8.  Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease.

Authors:  S Den Boon; E D Bateman; D A Enarson; M W Borgdorff; S Verver; C J Lombard; E Irusen; N Beyers; N W White
Journal:  Int J Tuberc Lung Dis       Date:  2005-10       Impact factor: 2.373

9.  Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.

Authors:  Stephen D Lawn; Landon Myer; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

10.  Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa.

Authors:  J H Day; S Charalambous; K L Fielding; R J Hayes; G J Churchyard; A D Grant
Journal:  Int J Tuberc Lung Dis       Date:  2006-05       Impact factor: 2.373

View more
  40 in total

1.  Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

Authors:  Grant Theron; Anil Pooran; Jonny Peter; Richard van Zyl-Smit; Hridesh Kumar Mishra; Richard Meldau; Greg Calligaro; Brian Allwood; Surendra Kumar Sharma; Rod Dawson; Keertan Dheda
Journal:  Eur Respir J       Date:  2011-11-10       Impact factor: 16.671

2.  The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients.

Authors:  Grant Theron; Lancelot Pinto; Jonny Peter; Hemant Kumar Mishra; Hridesh Kumar Mishra; Richard van Zyl-Smit; Surendra Kumar Sharma; Keertan Dheda
Journal:  Clin Infect Dis       Date:  2011-12-01       Impact factor: 9.079

3.  Impact of a training course on the quality of chest radiography to diagnose pulmonary tuberculosis.

Authors:  A Ohkado; P Luna; A Querri; M Mercader; S Yoshimatsu; L Coprada; R Bañares; A M C Garfin; T Date
Journal:  Public Health Action       Date:  2015-03-21

4.  High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay.

Authors:  Stephen D Lawn; Andrew D Kerkhoff; Monica Vogt; Robin Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2012-07-01       Impact factor: 3.731

5.  Tuberculosis screening in patients starting antiretroviral therapy in sub-Saharan Africa: stretching diagnostics to the limits.

Authors:  Stephen D Lawn; Robin Wood
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

6.  Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.

Authors:  Stephen D Lawn; Katharina Kranzer; David J Edwards; Matthew McNally; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

7.  Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?

Authors:  D I Ling; M Pai; V Davids; L Brunet; L Lenders; R Meldau; G Calligaro; B Allwood; R van Zyl-Smit; J Peter; E Bateman; R Dawson; K Dheda
Journal:  Eur Respir J       Date:  2011-02-24       Impact factor: 16.671

8.  Tuberculosis Diagnostic Committees' contribution to the National TB Program in Manila and Quezon Cities.

Authors:  A Querri; A Ohkado; R Poblete; P Agujo; F Tang; E Arias; A Medina; M Mantala; R Vianzon; J Lagahid; A Shimouchi
Journal:  Public Health Action       Date:  2012-08-22

9.  Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study.

Authors:  J Lucian Davis; William Worodria; Harriet Kisembo; John Z Metcalfe; Adithya Cattamanchi; Michael Kawooya; Rachel Kyeyune; Saskia den Boon; Krista Powell; Richard Okello; Samuel Yoo; Laurence Huang
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

10.  The risk and timing of tuberculosis diagnosed in smear-negative TB suspects: a 12 month cohort study in Harare, Zimbabwe.

Authors:  Munyaradzi Dimairo; Peter MacPherson; Tsitsi Bandason; Abbas Zezai; Shungu S Munyati; Anthony E Butterworth; Stanley Mungofa; Simba Rusikaniko; Katherine Fielding; Peter R Mason; Elizabeth L Corbett
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.